Dr. Mena Boules | Intestinal Failure | Research Excellence Award

Ironwood Pharmaceuticals | United States

A senior medical affairs executive with extensive experience leading global strategies across gastroenterology and rare disease portfolios. Recognized for integrating scientific, clinical, and business insights to position Medical Affairs as a strategic command center focused on patient outcomes. Expertise includes evidence generation, real-world data, publications, scientific communications, field medical operations, and external engagement. Demonstrated track record of translating clinical and analytical data into impactful product and medical strategies, supported by a substantial body of peer-reviewed publications, abstracts, and industry presentations. Active contributor to professional societies and governance committees, with strong leadership in cross-functional execution and stakeholder collaboration.

Citation Metrics (Scopus)

900
700
500
300
100
0

Citations
834

Documents
54

h-index
16

Citations

Documents

h-index

Featured Publications

Long-term Safety and Efficacy of Budesonide Oral Suspension for Eosinophilic Esophagitis:
A 4-Year, Phase 3, Open-Label Study
– Clinical Gastroenterology and Hepatology, 2025
Impaired Health-Related Quality of Life in Patients With Short Bowel Syndrome Dependent on Parenteral Support:
Results From a Multinational Survey
– American Journal of Gastroenterology, 2025
Clinical and Psychological Burden Among Patients With Short Bowel Syndrome Requiring Parenteral Support:
Findings From a Multinational Survey
– American Journal of Gastroenterology, 2025
Once-Weekly Apraglutide Reduces Parenteral Support Volume and Improves Clinical Response Rates:
STARS Extend Trial
– American Journal of Gastroenterology, 2025
Mena Boules | Intestinal Failure | Research Excellence Award

You May Also Like